New Jersey S 518: Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2026-01-13)

State: New Jersey · Session: 222 · Bill: S 518

Sponsors: Beach, James

View New Jersey S 518 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.